By 2022, Cancer is Now a More Chronic Disease with Chronic Difficulties to Go Along with It

ArticleAçık Erişim

Özet

Cancer is a disease in which some body cells with genetic or epigenetic changes become capable of replicating and invading other regions of the body uncontrollably. Numerous functional abilities and features are acquired by these cells during this multistage neo¬plastic process. In the last 20 years, many agents have been discovered and used in the fight against cancer. However, the use of these drugs in appropriate patient groups is still a serious problem. Many cancer types are on the way to becoming chronic diseases; conscientious physi¬cians who are unable to provide appropriate treatment due to economic factors and other reasons face an additional burden. © 2022 by Turkish Society of Medical Oncology.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12604Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.37047/jos.2022-90068Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorSumbul, Ahmet Taner
dc.contributor.authorSedef, Ali Murat
dc.contributor.authorKaracin, Cengiz
dc.contributor.authorBilir, Cemil
dc.contributor.authorAkagunduz, Baran
dc.date.accessioned2026-10-18T20:27:29.115325301Z
dc.date.available2026-10-18T20:27:29.115325301Z
dc.date.issued2022
dc.description.abstractCancer is a disease in which some body cells with genetic or epigenetic changes become capable of replicating and invading other regions of the body uncontrollably. Numerous functional abilities and features are acquired by these cells during this multistage neo¬plastic process. In the last 20 years, many agents have been discovered and used in the fight against cancer. However, the use of these drugs in appropriate patient groups is still a serious problem. Many cancer types are on the way to becoming chronic diseases; conscientious physi¬cians who are unable to provide appropriate treatment due to economic factors and other reasons face an additional burden. © 2022 by Turkish Society of Medical Oncology.
dc.identifier.doi10.37047/jos.2022-90068
dc.identifier.endpage6
dc.identifier.issn2651-4532
dc.identifier.issue1
dc.identifier.scopus2-s2.0-85132561183
dc.identifier.startpage1
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12604
dc.identifier.volume8
dc.language.isoen
dc.publisherTurkiye Klinikleri
dc.relation.ispartofJournal of Oncological Science
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCancer
dc.subjectChronic disease
dc.subjectNovel drugs
dc.subjectantibody drug conjugate
dc.subjectantineoplastic agent
dc.subjectneurotrophic tyrosine receptor kinase inhibitor
dc.subjectnicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor
dc.subjectprotein tyrosine kinase inhibitor
dc.subjectunclassified drug
dc.subjectArticle
dc.subjectcancer chemotherapy
dc.subjectcancer immunotherapy
dc.subjecteconomic aspect
dc.subjecthuman
dc.subjectmalignant neoplasm
dc.subjectphysician
dc.titleBy 2022, Cancer is Now a More Chronic Disease with Chronic Difficulties to Go Along with It
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus1
rdl.citation.trdizin0
rdl.departmentT.C. SAĞLIK BAKANLIĞI
rdl.departmentSAĞLIK BİLİMLERİ ÜNİVERSİTESİ
rdl.departmentBAŞKENT ÜNİVERSİTESİ
rdl.departmentÖzel Kuruluş
rdl.departmentERZİNCAN BİNALİ YILDIRIM ÜNİVERSİTESİ
rdl.oa.statusgold
rdl.source.indexSCOPUS
rdl.source.indexTRDIZIN